# Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX

> **NCT00710619** · — · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 52 (actual)

## Conditions studied

- Congenital Bleeding Disorder
- Haemophilia A With Inhibitors
- Haemophilia B With Inhibitors

## Interventions

- **DRUG:** activated recombinant human factor VII
- **DRUG:** Feiba VH

## Key facts

- **NCT ID:** NCT00710619
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-06
- **Primary completion:** 2009-07
- **Final completion:** 2009-07
- **Target enrollment:** 52 (ACTUAL)
- **Last updated:** 2016-11-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00710619

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00710619, "Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00710619. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*